Author | Cheryl Guttman Krader; Reviewed by Dr Albert J. Augustin


DMO study shows robust efficacy of intravitreal dexamethasone implant

In a real-world study of patients with treatment-naïve and previously treated diabetic macular oedema, injection of intravitreal dexamethasone 0.7-mg implant provided effective disease control with initial and repeat injections, regardless of reinjection interval.